Novavax Inc is trading 5.3% up today at $9.01, bouncing back after several recent down sessions in tandem with a strong rebound in major U.S. indices.
- The move appears driven by a broad market rally in growth and higher-beta names rather than new company-specific fundamentals.
- No fresh headlines or analyst calls have emerged for the stock as of June 11, 2026.
- The price action reflects improving risk sentiment across the healthcare sector and the wider market.